Torrent Pharma Recalls Robafen Cough Formula Due to Potential Bacterial Contamination
Torrent Pharma is recalling Robafen Cough Formula Expectorant due to potential contamination with Burkholderia cepacia and Ralstonia pickettii.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves potential contamination with specific bacterial pathogens, which aligns with the rubric criteria for Severe severity.
Plain-English summary
Torrent Pharma Inc is recalling Robafen Cough Formula Expectorant (guaifenesin USP 200 mg in each 10 mL) in 4 Fl. oz. and One Pint bottles. The recall involves 984,888 bottles distributed by Major Pharmaceuticals. The product was distributed to 9 distributors, direct accounts, and relabelers who may have further distributed the product throughout the United States.
The recall is being conducted due to cGMP deviations that resulted in potential product contamination with Burkholderia cepacia (B. cepacia) and Ralstonia pickettii (R. pickettii). The agency has classified this as a Class II recall.
Consumers should check their inventory for the specific lot numbers and expiration dates listed in the official recall notice. If the product matches the recalled lots, consumers should stop using it and contact the distributor or manufacturer for instructions on return or disposal.
The recalled product
- Product
- Robafen Cough Formula Expectorant (guaifenesin USP 200 mg in each 10 mL), a) 4 Fl. oz. (118 mL) bottle, NDC: 0904-0061-00, b) One Pint ( 473 mL) bottle, NDC: 0904-0061-16, Distributed by Major Pharmaceuticals, Livonia MI 48152.
- Manufacturer
- Torrent Pharma Inc
- Category
- Drug — Cough Medicine
- Hazard
- Affected units
- 984,888
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #s: a) 17F003
- Exp. 06/2019
- 17J011
- Exp. 09/2019
- 17K018
- 17K020
- Exp. 10/2019
- 17M014
- 17M034
- Exp. 12/2019
- 18A035
- Exp. 01/2020
- 18B022
- 18B027
- Exp. 02/2020
- 18C036
- Exp. 03/2020
- 18D009
- 18D024
- Exp. 04/2020. b) 17G018
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 41 recalled by Torrent Pharma Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 41 products in this recall →Related recalls
Same manufacturer · Torrent Pharma Inc
See all →- HighFluoxetine Tablets USP 20 mg Recalled for N-Nitroso Contamination
FDA (Drugs) · 2025-06-11
- SevereFluoxetine Tablets 20 mg Recalled for N-Nitroso Impurity
FDA (Drugs) · 2025-06-11
- High
- ModerateCarbamazepine tablets recalled for failed dissolution specifications
FDA (Drugs) · 2022-01-19
- ModerateTelmisartan and Hydrochlorothiazide Tablets Recalled for Superpotency
FDA (Drugs) · 2021-12-22
Same hazard · bacterial contamination
See all →- HighClorox Recalls Scented Mistolin and Lestoil Cleaners in Puerto Rico
CPSC · 2026-09-03
- HighCurry chicken salad flagged for possible Listeria contamination in two states
USDA FSIS · 2026-07-30
- ModerateMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- SevereSurgical Convenience Kit Recalled for Bacterial Contaminant in Alcohol Prep Pads
FDA (Devices) · 2026-07-08